Condition
Amoxicillin-clavulanate
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06426836Not ApplicableRecruiting
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
NCT02456974Recruiting
Antibiotic Dosing in Pediatric Intensive Care
NCT06929702Phase 4Not Yet RecruitingPrimary
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
Showing all 3 trials